WHO ICTRP trial
Study on the application of A2 subtype genotyping in transplantation and blood…
ChiCTR1900028016 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR1900028016 |
|---|---|
| Public title | Study on the application of A2 subtype genotyping in transplantation and blood transfusion |
| Scientific title | Study on the application of A2 subtype genotyping in transplantation and blood transfusion |
| Primary sponsor | Tianjin First Central Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Basic Science |
| Phase | Retrospective study |
| Countries | China |
| Conditions | Blood group subtype |
| Interventions | Case series:None |
| Registration date | Dec 8, 2019 |
| Target size | Case series:1000 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: